Dr. Sainath Bhethanabhotla ,MD (Pediatrics), DM (AIIMS, Medical Oncology) - Try Second Opinion

Dr. Sainath Bhethanabhotla ,MD (Pediatrics), DM (AIIMS, Medical Oncology)

Profile and Area of Expertise

Dr. Sainath Bhethanabhotla is talented and eminent medical oncologist with good work experience. He is a Consultant Medical Oncologist and Pediatric Hemato – Oncologist at Care cancer Institute, Care Hospitals, Hyderabad. His key areas of interests include Hodgkin lymphoma, especially in pediatric and neonatal patient population.

Areas of Expertise:

  • Specialist in Pediatric Tumors & BMT
  • Gastro Intestinal & Genito Urinary Cancers
Experience (Current Position & Previous Positions)

Current Position:

  • CARE Super Specialty Hospital & Transplant Centre – Banjara Hills,Hyderabad.

Previous Positions:

  • Consultant Medical Oncology at Krishna Institute of Medical Sciences
  • Resident Super Specialist at MNJ Institute of Oncology and Regional Cancer Center, Hyderabad
  • Senior Resident In Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi
Education & Certificates
  • MBBS from Osmania Medical College, Hyderabad in 2007
  • MD in Pediatrics from All India Institute of Medical Sciences in 2012
  • DM in Medical Oncology from Dr. BR Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences in 2016

Awards and Recognition:

  • Won Sorel Catherine Prize For Best Post Graduate in Pediatrics For The Year 2012.
  • Stood 2nd in NNF Gold Medal Paper For The Year 2012(1).
  • Received Scholarship For Oral Presentation in SIOP-2015, Cape Town, South Africa For The Abstract “OUTCOME OF PEDIATRIC HODGKIN LYMPHOMA TREATED WITH ABVD: A MULTICENTRIC ANALYSIS OF 335 PATIENTS”.
  • Awarded “Abstract Achievement Award” at American Society of Hematology Meeting on Hematological Malignancies Held in Chicago on 16th,17th September ,2016 For The Abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 Patients”
Publications & Presentations
  • Bhethanabhotla S, Bakhshi S. Reply: Neither Post-Treatment PET-CT Nor Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma. J Nucl Med. 2016 Dec8;IMPACT FACTOR: 7.439
  • Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Et Al. Outcome Of Pediatric Advanced Hodgkin Lymphoma Treated With ABVD And Predictors Of Inferior Survival: A Multicenter Study Of 186 Patients. Leuk Lymphoma. 2016 Dec 6;1–7. IMPACT FACTOR:2.644
  • Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Et Al. Post- Treatment PET-CT Rather Than Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET-CT Versus Conventional Imaging. J Nucl Med. 2016 Oct 6; IMPACT FACTOR: 7.439
  • Bhethanabhotla S, Bakhshi S. Presence Of Risk Factors Does Not Affect Outcome In Early Stage Pediatric Hodgkin Lymphoma Treated With ABVD. Ann Hematol. 2016 Nov 18; IMPACT FACTOR: 2.845
  • Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role Of (18)F-FDG PET-CT In Monitoring The Cyclophosphamide Induced Pulmonary Toxicity In Patients With Breast Cancer – 2 Case Reports. Nucl Med Mol Imaging. 2016 Sep;50(3):261–5.
  • Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D, Gogia A, Et Al. Primary Diffuse Large B-Cell Lymphoma Of The Prostate: A Report Of Two Cases With Diagnostic Considerations. J Cancer Res Ther. 2015 Dec;11(4):977–9. IMPACT FACTOR: 0.8459
  • Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Et Al. Synchronous Metastatic Pulmonary Adenocarcinoma With Small Cell Lymphoma. Leuk Lymphoma. 2014 Jul;55(7):1678–80. IMPACT FACTOR: 2.644
  • Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect Of Position Of Infant During Phototherapy In Management Of Hyperbilirubinemia In Late Preterm And Term Neonates: A Randomized Controlled Trial. J Perinatol. 2013 Oct;33(10):795–9. IMPACT FACTOR: 2.183
  • Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Et Al. Autologous Stem Cell Transplantation For Multiple Myeloma: Long-Term Results. The National Medical Journal Of India. 2016 Jul 1;29(4):192. IMPACT FACTOR: 0.786
  • Bhethanabhotla, S., Tiwari, A., Sharma, M.C. Et Al. Prognostic Significance Of IL-6 In Hodgkin Lymphoma. Indian J Pediatr. 2019 Mar 4;Online First. IMPACT FACTOR: 1.046
  • Patel A, Tannock I, Bhethanabhola S, Srivastva P, Biswas B, Et Al. Low-Dose Abiraterone In Metastatic Prostate Cancer: Is It Practice Changing? Facts And Facets.JCO Glob Oncol. 2020 Mar;6:382-386. IMPACT FACTOR:1.79
  • American Society of Clinical Oncology (ASCO)

English, Telugu

Find cures for diseases

None found

Try us for Free

Find cures for diseases

None found